Bioxytran (BIXT) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free BIXT Stock Alerts $0.11 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Bioxytran Short Interest DataCurrent Short Volume7,900 sharesPrevious Short Volume56,600 sharesChange Vs. Previous Month-86.04%Dollar Volume Sold Short$1,151.98Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares174,960,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume134,267 sharesAverage Trading Volume98,916 sharesToday's Volume Vs. Average136% Short Selling Bioxytran ? Sign up to receive the latest short interest report for Bioxytran and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIXT Short Interest Over TimeBIXT Days to Cover Over TimeBIXT Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Bioxytran Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20247,900 shares $1,151.98 -86.0%N/A0 $0.15 3/31/202456,600 shares $5,988.28 +4.0%N/A0.5 $0.11 3/15/202454,400 shares $6,049.28 +92.9%N/A0.3 $0.11 2/29/202428,200 shares $3,102.00 No ChangeN/A0.2 $0.11 1/15/20241,700 shares $244.12 -89.5%N/A0 $0.14 12/31/202316,200 shares $2,430.00 -46.9%N/A0 $0.15 Get the Latest News and Ratings for BIXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bioxytran and its competitors with MarketBeat's FREE daily newsletter. 12/15/202330,500 shares $4,479.84 No ChangeN/A0.1 $0.15 11/15/202347,500 shares $7,120.25 +268.2%N/A0.4 $0.15 10/31/202312,900 shares $1,999.50 -77.0%N/A0.1 $0.16 10/15/202356,100 shares $9,537.00 +2.2%N/A0.5 $0.17 9/30/202354,900 shares $9,333.00 +173.1%N/A0.2 $0.17 9/15/202320,100 shares $3,015.00 -71.6%N/A0 $0.15 8/31/202370,700 shares $21,917.00 +644.2%N/A0.3 $0.31 8/15/20239,500 shares $1,368.00 +106.5%N/A0.2 $0.14 7/31/20234,600 shares $687.70 -87.9%N/A0 $0.15 7/15/202338,100 shares $5,715.00 -25.3%N/A0.4 $0.15 6/30/202351,000 shares $9,690.00 +4,150.0%N/A0.2 $0.19 6/15/20231,200 shares $276.00 -62.5%N/A0 $0.23 5/31/20233,200 shares $1,025.60 +88.2%N/A0.1 $0.32 5/15/20231,700 shares $680.00 -96.0%N/A0 $0.40 4/30/202342,900 shares $21,771.75 +263.6%N/A0.7 $0.51 4/15/202311,800 shares $5,742.77 -9.2%N/A0.1 $0.49 3/31/202313,000 shares $5,785.00 +14.0%N/A0.1 $0.45 3/15/202311,400 shares $5,141.40 No ChangeN/A0 $0.45 2/15/2023700 shares $292.25 No ChangeN/A0 $0.42 1/15/202317,400 shares $7,830.00 -17.1%N/A0.3 $0.45 12/30/202221,000 shares $10,080.00 +577.4%N/A0.2 $0.48 12/15/20223,100 shares $1,289.60 +121.4%N/A0 $0.42 11/30/20221,400 shares $588.14 -90.1%N/A0 $0.42 11/15/202214,200 shares $7,100.00 +136.7%N/A0.1 $0.50 10/31/20226,000 shares $2,400.00 +185.7%N/A0.1 $0.40 10/15/20222,100 shares $1,071.00 No ChangeN/A0 $0.51 9/15/20227,400 shares $6,956.00 -54.6%N/A0 $0.94 8/31/202216,300 shares $16,952.00 +3,160.0%N/A0.1 $1.04 8/15/2022500 shares $255.00 -73.7%N/A0 $0.51 7/31/20221,900 shares $798.00 -88.3%N/A0 $0.42 7/15/202216,200 shares $8,908.38 No ChangeN/A0.1 $0.55 12/31/2021300 shares $120.00 No ChangeN/A0 $0.40 12/15/2021300 shares $0.75 -25.0%N/A0.1 $0.00 11/30/2021400 shares $8.00 No ChangeN/A0.1 $0.02Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details BIXT Short Interest - Frequently Asked Questions What is Bioxytran's current short interest? Short interest is the volume of Bioxytran shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 7,900 shares of BIXT short. Learn More on Bioxytran's current short interest. Is Bioxytran's short interest increasing or decreasing? Bioxytran saw a drop in short interest in April. As of April 15th, there was short interest totaling 7,900 shares, a drop of 86.0% from the previous total of 56,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Bioxytran's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Bioxytran: Galecto, Inc. (0.09%), NeuroBo Pharmaceuticals, Inc. (2.63%), Orgenesis Inc. (1.17%), Indaptus Therapeutics, Inc. (1.46%), Vincerx Pharma, Inc. (8.91%), NeuroSense Therapeutics Ltd. (0.76%), Talphera, Inc. (0.65%), KALA BIO, Inc. (0.21%), Aptorum Group Limited (1.89%), BioVie Inc. (2.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Bioxytran stock? Short selling BIXT is an investing strategy that aims to generate trading profit from Bioxytran as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bioxytran? A short squeeze for Bioxytran occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BIXT, which in turn drives the price of the stock up even further. How often is Bioxytran's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIXT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Galecto Short Interest Data NeuroBo Pharmaceuticals Short Interest Data Orgenesis Short Interest Data Indaptus Therapeutics Short Interest Data Vincerx Pharma Short Interest Data NeuroSense Therapeutics Short Interest Data Talphera Short Interest Data KALA BIO Short Interest Data Aptorum Group Short Interest Data BioVie Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BIXT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders“Crash Insurance” For Your RetirementUnstoppable ProsperityThe #1 Crypto for AIWeiss Ratings